Text Size:AAA

IFNA5/IFNaG Protein, Antibody, ELISA Kit, cDNA Clone

Description: Active
Expression host: Human Cells
  • Slide 1
10342-H01H-5
10342-H01H-50
10342-H01H-100
5 µg / $38
50 µg / $138
100 µg / $248
Add to Cart
Description: Active
Expression host: Human Cells
  • Slide 1
80205-R08H-50
80205-R08H-100
80205-R08H-5
50 µg / $178
100 µg / $298
5 µg / $38
Add to Cart

IFNA5/IFNaG Related Areas

IFNA5/IFNaG Related Pathways

IFNA5/IFNaG Related Product

IFNA5/IFNaG Summary & Protein Information

IFNA5/IFNaG Related Information

IFNA5/IFNaG Background

Subcellular location: Secreted.
Sequence similarity: Belongs to the alpha/beta interferon family.C
General information above from UniProt

Interferon, alpha 5 (IFNA5) belongs to the alpha/beta interferon family. IFNA5 is the only IFNA subtype detected in normal liver, while a mixture of subtypes is observed in the liver tissue of patients with chronic hepatitis C. Interferons are produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. IFN-alpha, the first cytokine to be produced by recombinant DNA technology, has emerged as an important regulator of growth and differentiation, affecting cellular communication and signal transduction pathways as well as immunological control. Originally discovered as an antiviral substance, the efficacy of IFN-alpha in malignant, viral, immunological, angiogenic, inflammatory, and fibrotic diseases suggests a spectrum of interrelated pathophysiologies. IFN-alpha emerged as a prototypic tumor suppressor protein that represses the clinical tumorigenic phenotype in some malignancies capable of differentiation.

IFNA5/IFNaG Alternative Name

IFNA5/IFNaG Related Studies

  • Lau JY, et al. (1993) Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet. 342(8881): 1208-9.
  • Kessler DS, et al. (1990) Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev. 4(10): 1753-65.
  • Gutterman JU. Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci U S A. 91(4): 1198-205.
  • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"